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Leprosy, a chronic human disease with potentially debilitating neurological 
consequences, results from infection with Mycobacterium leprae.  This unculturable 
pathogen has undergone extensive reductive evolution with half of its genome now 
occupied by pseudogenes.  Using comparative genomics we demonstrated that all extant 
cases of leprosy are attributable to a single clone whose dissemination worldwide can be 
retraced from analysis of very rare single nucleotide polymorphisms (SNP).  The disease 
seems to have originated in Eastern Africa or the Near East and spread with successive 
human migrations.  Europeans or North Africans introduced leprosy into West Africa 
and the Americas within the past 500 years. 
 
Comparative genomics enables us to establish solid genealogical relationships with greater 
precision than ever before.  Leprosy (1) has plagued human populations for thousands of 
years and puzzled scientists since the identification of its etiological agent, Mycobacterium 
leprae, by Hansen in 1873 (2).  The main difficulty of working with M. leprae is that it cannot 
be grown in axenic culture and its doubling time in tissue is slow, nearly 13 days (3).  It was 
only when it was discovered that the nine banded armadillo, Dasypus novemcinctus, could be 
infected (4) that sufficient quantities of M. leprae were obtained for biological and 
immunological analysis.  Comparison of the genome sequence of the armadillo-passaged 
strain of M. leprae from Tamil Nadu, India (TN strain) with that of the close relative 
Mycobacterium tuberculosis (5), led to a major breakthrough (6).  M. leprae was shown to 
have embarked upon a path of reductive evolution in which the genome underwent 
downsizing and accumulated over 1,130 pseudogenes.  The concomitant loss of catabolic and 
respiratory functions appears to have resulted in severe metabolic constraints (6, 7).   
 To establish whether all strains of M. leprae had undergone similar events and to 
determine their level of relatedness we used technological approaches that have successfully 
detected polymorphic regions in the M. tuberculosis complex (8-10).  First, genomic DNA, 
prepared from seven different strains of leprosy bacilli (Table 1), was hybridized to 
microarrays corresponding to the complete genome of the TN strain but no evidence for 
further gene loss was uncovered in these isolates (Figure S1).  Second, to establish whether 
differences existed in the copy number of Insertion Sequence-like, dispersed repetitive 
sequences, quantitative PCR was performed to target the repetitive sequences RLEP, 
REPLEP, LEPREP, and LEPRPT (11).  Again, within the limits of sensitivity of this 
approach, no differences were detected between the TN strain and the other isolates (Figure 
S2).   
A major source of variability in tubercle bacilli is the mycobacterial interspersed 
repetitive unit (MIRU) which serves as the basis of a robust typing system that exploits 
differences in the variable number of the tandem repeats (VNTR) that make up this repetitive 
element (12).  Unlike, M. tuberculosis, none of the 20 MIRU loci in the TN strain contains 
tandem repeats of the element (11) and, on examination of the additional strains, no copy 
number differences were detected.  Furthermore, the 20 MIRUs were of identical sequence in 
all seven strains studied (Table 1).  Seven other VNTR, with 2 – 6 bp repeats, were also 
targeted, as some of them have proved useful for tracking strains over short epidemiological 
distances (13-16).  No variation was seen in a hexanucleotide repeat situated within the 
coding sequence of the sigA (rpoT) gene (17) whereas on examination of two trinucleotide- 
and four dinucleotide-repeats, located in pseudogenes or non-coding regions of the genome, 
extensive differences were seen in copy number (Table 1). However, as expected for such 
sequences, that are highly prone to slipped strand mispairing during replication (18), the level 
of variability was too great to allow patterns to be detected. 
While these results rule out the existence of the most likely insertion and deletion 
events they are less informative about genome topology and global organization.  These 
features were surveyed by fingerprinting and end-sequencing 1,466 cosmids from a library of 
a second Indian strain of M. leprae leading to an integrated genome map that showed perfect 
co-circularity with that of the TN strain (19, 20).  To increase the likelihood of detecting 
single nucleotide polymorphisms (SNP), selected genes, non-coding regions and pseudogenes 
were sequenced from a Brazilian strain, Br4923 (Table S1), that was chosen for two reasons; 
the relative geographic remoteness of the country and the severity of the disease burden in 
Brazil which is second highest worldwide after India (1).  By this means, five SNPs were 
revealed in 142 kb of sequenced DNA: one in an apparently non-coding region and four in 
pseudogenes.  When all seven strains were analyzed only three of the SNPs were found in two 
or more of the strains tested (Figure 1A) while the remaining two were restricted to the TN 
strain of M. leprae.  Overall, the SNP frequency observed in M. leprae of ~1 per 28 kb was 
significantly less than that seen in other human pathogens like the tubercle bacilli (8, 9, 21, 
22), Salmonella typhi (23), and Helicobacter pylori (24) (Table 2).  Taken together, these 
findings indicate that the M. leprae genome is exceptionally well-conserved and that the 
leprosy bacillus is highly clonal (25).  
To gain insight into the worldwide distribution of the M. leprae SNPs, we sought the 
three informative SNPs in a total of 175 clinical and laboratory specimens from 21 countries, 
and all five continents.  We discovered that of a possible 64 permutations only four occurred 
(Tables 3 and S2), referred to as SNP-types 1 – 4.  When the VNTR panel was probed, 
extensive variability was found for six VNTRs (Table S2) but no particular VNTR pattern 
was associated with a given SNP-type.  In contrast, a correlation exists between the 
geographical origin of the leprosy patient and the SNP profile, as type 1 occurs predominantly 
in Asia, the Pacific region and East Africa, type 4 in West Africa and the Caribbean region, 
and type 3 in Europe, North Africa and the Americas.  SNP-type 2 is the rarest and has only 
been detected in Ethiopia, Malawi, Nepal/North India and New Caledonia.   
Ancient texts describe the existence of leprosy in China, India and Egypt about 600BC 
and skeletal remains bearing hallmarks of the disease have been found in Egypt (26).  Leprosy 
is believed to have originated in the Indian subcontinent and to have been introduced into 
Europe by Greek soldiers returning from the Indian campaign of Alexander the Great (26).  
From Greece, the disease is thought to have spread around the Mediterranean basin with the 
Romans introducing leprosy into the Western part of Europe.  Little is known about sub-
Saharan Africa except that the disease was present prior to the colonial era.  From India 
leprosy is thought to have spread to China, and then to Japan, reaching Pacific Islands like 
New Caledonia as recently as the 19
th
 century. 
Our results provide evidence for a general evolutionary scheme for M. leprae and, 
based on our interpretation of the SNP data, offer two alternative conclusions for the global 
spread of leprosy that differ from classical explanations. Two equally plausible evolutionary 
scenarios are possible (Figures 1B, 2).  In the first, SNP-type 2, from East Africa/Central 
Asia, preceded type 1, which migrated eastward, and type 3, which disseminated westward in 
human populations, before giving rise to type 4.  In the second scenario, type 1 was the 
progenitor of type 2 with SNP-types 3 and 4 following in that order.  
Leprosy was most likely introduced into West Africa by infected explorers, traders or 
colonialists of European or North African descent, rather than by migrants from East Africa, 
as SNP-type 4 is much closer to type 3, than to type 1 (Figure 1B).  West and Southern Africa 
are thought to have been settled >50,000 years ago by migrants from East Africa before the 
arrival of humans in Eurasia (27, 28).  It seems unlikely that early humans brought leprosy 
into West Africa with them unless that particular bacterial clone has since been replaced.  
From West Africa, leprosy was then introduced by the slave trade in the 18
th
 century to the 
Caribbean islands, Brazil, and probably other parts of South America, as isolates of M. leprae 
with the same SNP-type, 4, are found there as in West Africa. 
The strain of M. leprae responsible for disease in most of the Americas is closest to 
the European/North African variety (Figure 1B) indicating that colonialism and emigration 
from the old world most probably contributed to the introduction of leprosy into the New 
World.  For instance, in the 18
th
 and 19
th
 centuries, when the mid-western states of the USA 
were settled by Scandinavian immigrants, many cases of leprosy were reported and, at that 
time, a major epidemic was underway in Norway (26).  Further support for this hypothesis is 
provided by the finding that wild armadillos from Louisiana, USA, which are naturally-
infected with M. leprae, harbor the European/North African SNP-type 3 strain indicating that 
they were contaminated from human sources.  While most mycobacteria occur in the soil, 
there is no convincing evidence for an environmental reservoir of M. leprae and, apart from 
armadillos, which have limited geographical distribution and only very recently became 
infected, there is no known animal source of the pathogen.  Although an ancient zoonotic 
origin cannot be excluded, insect bites may also have been a possible route of early human 
infection, particularly as recent studies show that Mycobacterium ulcerans, a related pathogen 
with many pseudogenes, appears to be transmitted by aquatic insects (29). 
In conclusion, M. leprae, with its exceptionally stable genome, is a helpful marker for 
tracking the migration of peoples and retracing the steps that led to modern human 
populations.  In this respect, it complements H. pylori, which is considerably more diverse 
and thus allows finer understanding of the ethnic origin of humans (30). It is noteworthy that 
the greatest variety of SNP types in the leprosy bacillus is found in islands such as the French 
West Indies and New Caledonia (Figure 2) reflecting the passage of, and settlement by, 
different human populations.  Finally, the remarkable clonality seen in isolates of M. leprae 
indicates that genome decay occurred prior to global spread of leprosy and that it has not 
accelerated significantly since.   
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 Legends to figures. 
Figure 1.  SNP analysis of isolates of different geographical origin and parsimony. A.  
Comparison of polymorphic sites in the genomes of the TN and Br4923 strains by automated 
DNA sequencing.  Coordinates are the position in the genome of the TN strain and the 
vertical bar indicates the polymorphic base.  B. The most parsimonious route to account for 
the four SNP-types. Bold arrows indicate the most likely direction, based on historical and 
geographic considerations, while the faint arrow denotes an alternative route. 
 
Figure 2.  Dissemination of leprosy in the world.  The circles indicate the country of origin of 
the samples examined and their distribution into the four SNP types which are color-coded as 
in Figure 1B.  The colored arrows indicate the direction of human migrations predicted by, or 
inferred from, our SNP analysis; hatched black arrows correspond to the migration routes of 
humans derived from genetic, archaeological and anthropological studies with the estimated 
time of migration in years (27, 28). 
 
 Table 1.  Strains of armadillo-derived M. leprae and VNTR-profile 
 
Strain Patient’s 
country 
of origin 
Source 3-
Hexa* 
21-
TTC 
9-
GTA 
14-
AT 
15-
AT 
17-
AT 
18-
AT 
Tamil 
Nadu 
India IP 3 21 9 14 15 17 18 
Africa Ethiopia IP 3 29 8 14 19 13 13 
India 2 India IP 3 15 11 18 14 13 9 
Br4923 Brazil NHDP 3 12 12 20 20 15 18 
NHDP98 Mexico CSU/NHDP 3 10 9 22 14 11 12 
Thai-53 Thailand CSU/NHDP 3 15 9 16 17 10 13 
NHDP63 USA CSU/NHDP 3 10 10 18 18 13 16 
          
*, numbers refer to the repeat copy number in the Tamil Nadu strain (11) while those in the 
Table are the copy numbers found in the respective isolates.  IP, Institut Pasteur; NHDP, 
National Hansen’s Disease Program; CSU, Colorado State University. 
  
Table 2. Comparison of SNP frequency in other bacterial pathogens  
 
 
Pathogen    SNP frequency/bp  Reference 
M. leprae    1 in 28,400   This work 
M. tuberculosis complex  1 in ~3,000   21, 22 
S. typhi    1 in 1,112   23 
H. pylori    1 in 3.2   24 
____________________________________________________________________ 
  
Table 3. SNP analysis of M. leprae from different countries 
 
     
Country SNP-type 1 SNP-type 2 SNP-type 3 SNP-type 4 
New-Caledonia 3 1 3  
Philippines 19  2  
Korea 3  2  
Thailand 1    
Nepal/North India 23 5   
South India 4    
Madagascar 6    
Ethiopia  2   
Malawi 4 6   
Mali    31 
Ivory Coast    6 
Guinea    1 
Senegal    2 
Morocco   2  
France   2  
Brazil   12 2 
French West Indies 4  2 14 
Venezuela   5  
Mexico   1  
USA   3  
WARM*   4  
Total 67 14 38 56 
*, Wild armadillos from Louisiana, USA 
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